Kelly M Cordoro
Overview
Explore the profile of Kelly M Cordoro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
2368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crockett J, Kim S, von Scheven E, Mathur A, Cordoro K
Pediatr Dermatol
. 2024 Oct;
42(1):41-46.
PMID: 39420750
Background/objectives: Integrated care models, like combined rheumatology/dermatology clinics (RDCs), facilitate efficient coordination between specialists and provide comprehensive care. Given the limited literature on pediatric RDC logistics, outcomes, benefits and, challenges,...
2.
Crockett J, Cordoro K
Pediatr Dermatol
. 2024 Oct;
42(1):73-78.
PMID: 39420724
Background/objective: The demand for pediatric dermatology services in the U.S. is high, especially at large academic healthcare centers. eConsultation programs provide a solution to poor in-person access by offering diagnostic...
3.
Crockett J, Cordoro K
Pediatr Dermatol
. 2024 Jul;
41(6):1114-1116.
PMID: 39078081
Provider-to-provider outpatient pediatric dermatology eConsultation services increase access to care, but barriers exist that may prevent eConsult implementation and survival. We deployed cross-sectional surveys to referring pediatric primary care physicians...
4.
Crockett J, Copp H, Mully T, Francois R, Cordoro K
Pediatr Dermatol
. 2024 Jul;
41(6):1188-1192.
PMID: 38989723
Calcinosis cutis (CC) is characterized by the deposition of calcium salts in the skin and subcutaneous tissues. CC involving the vulva or foreskin (prepuce) is uncommon. We present a 9-year-old...
5.
Brandling-Bennett H, Arkin L, Chiu Y, Hebert A, Callen J, Castelo-Soccio L, et al.
J Am Acad Dermatol
. 2024 Feb;
90(6):1271-1275.
PMID: 38342248
No abstract available.
6.
Chat V, Ellebrecht C, Kingston P, Gondo G, Bell S, Cordoro K, et al.
J Am Acad Dermatol
. 2024 Feb;
90(6):1170-1181.
PMID: 38331098
Background: For psoriatic patients who need to receive nonlive or live vaccines, evidence-based recommendations are needed regarding whether to pause or continue systemic therapies for psoriasis and/or psoriatic arthritis. Objective:...
7.
Pritchett E, Cordoro K, Ayers L, Sokumbi O
J Am Acad Dermatol
. 2023 Oct;
90(2):346-348.
PMID: 37804937
No abstract available.
8.
Siegfried E, Arkin L, Chiu Y, Hebert A, Callen J, Castelo-Soccio L, et al.
Pediatr Dermatol
. 2023 Jun;
40(5):789-808.
PMID: 37316462
Methotrexate (MTX) is a readily accessible drug, first used in 1948 and employed for a wide variety of indications since then. However, despite widespread off-label use, FDA labeling does not...
9.
Pelet Del Toro N, Yahia R, Feldman S, Van Voorhees A, Green L, Schwartzman S, et al.
JAAD Int
. 2023 Jun;
12:32-36.
PMID: 37274387
Telemedicine emerged as an alternative care delivery system used to offer effective long-term management to patients with chronic, inflammatory conditions such as psoriatic disease. Teledermatology can provide reliable clinical information...
10.
Eickstaedt J, Paller A, Lund E, Murphrey M, Brandling-Bennett H, Maurano M, et al.
JAMA Dermatol
. 2023 Apr;
159(6):637-642.
PMID: 37043214
Importance: Tumor necrosis factor α (TNF) inhibitor-induced psoriasiform eruption is well recognized in adults, but few reports document this paradoxical effect in children. Objective: To characterize the clinical features and...